Wikidata

(Q61909715)

English

Study of Safety and Efficacy of C-CAR011 in B-NHL Patients

clinical trial

In more languages

Statements

title
Study of Safety and Efficacy of Anti-CD19 Chimeric Antigen Receptor T Cell(C-CAR011) Treatment in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (English)
0 references
start time
3 May 2017
0 references
end time
30 April 2018
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61909715&oldid=2149416934"